Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pulmonx Corp shares valued at $25,280 were sold by Ferrari Richard on Jun 12 ’25. At $3.16 per share, Ferrari Richard sold 8,000 shares. The insider’s holdings dropped to 87,024 shares worth approximately $0.14 million following the completion of this transaction.
Also, Ferrari Richard purchased 5,438 shares, netting a total of over 16,368 in proceeds.
Before that, RICH FERRARI had added 8,000 shares to its account. In a trade valued at $25,307, the Director bought Pulmonx Corp shares for $3.16 each.
As published in a research note from Piper Sandler on July 31, 2025, Pulmonx Corp [LUNG] has been rated down from an Overweight to a Neutral and the price target has been revised to $2.50. Analysts at D. Boral Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of December 11, 2024, Citigroup has decreased its “Buy” rating to a “Neutral” for LUNG. Earlier on June 04, 2024, Lake Street initiated its rating. Their recommendation was “a Buy” for LUNG stock.
Analyzing LUNG Stock Performance
On last trading session, Pulmonx Corp [NASDAQ: LUNG] rose 0.62% to $1.62. The stock’s lowest price that day was $1.59, but it reached a high of $1.705 in the same session. During the last five days, there has been a drop of approximately -11.96%. Over the course of the year, Pulmonx Corp shares have dropped approximately -72.86%.
Is Pulmonx Corp subject to short interest?
Stocks of Pulmonx Corp saw a sharp rise in short interest on 2025-07-15 jumping by 22350.0 shares to 1.44 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 1.42 million shares. A jump of 1.55% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.35.
Which companies own the most shares of Pulmonx Corp (LUNG)?
In terms of Pulmonx Corp share price expectations, FactSet research, analysts set an average price target of 2.5 in the next 12 months, up nearly 55.28% from the previous closing price of $1.61. Analysts anticipate Pulmonx Corp stock to reach 2.5 by 2025, with the lowest price target being 2.5. In spite of this, 4 analysts ranked Pulmonx Corp stock as Buy at the end of 2025. On February 23, 2024, Wells Fargo assigned a price target of “an Equal weight” to the stock and downgraded coverage with a $14.
